Is It Time for Treatment as Prevention of Chronic Hepatitis B?
Pathogens · 06.09.2023 · 12 (9) · 1137
DOI: 10.3390/pathogens12091137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 06.09.2023. Verfasst von Jose A Perez-Molina und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Centre for Tropical Diseases, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
Abstract (Originalsprache)
Hepatitis B is a major global health problem with high morbidity and mortality. Approximately 296 million people are living with chronic HBV, and 1.5 million new infections are detected each year, even though a highly effective vaccine has been available for decades and viral replication and transmission can be contained with the use of drugs. Nucleoside therapy, while not curative in most cases, can control viral replication, improve prognosis, and prevent mother-to-child transmission safely. Current treatment guidelines do not include a significant number of chronically infected patients or pregnant women and are often complex to implement. Since these populations continue to have a detectable HVB viral load, they could perpetuate transmission. Expanding and facilitating treatment indications, including treatment as a public health intervention, could help control the spread of the HBV pandemic, thus bringing us closer to the goal of the United Nations General Assembly for the year 2030.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Reference Centre for Tropical Diseases, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
- IRYCIS, Carretera de Colmenar Km 9.1, 28034 Madrid, Spain.
- CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Infectious Diseases Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
- Department of Medicine, Universidad de Alcalá, Alcalá de Henares, 28805 Madrid, Spain.
ORCID-Profile: Jose A Perez-Molina, Marta Rosas Cancio-Suárez
Förderung
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
- Instituto de Salud Carlos III, Madrid, Spain
Zitieren
APA
Perez-Molina, J. A., Cancio-Suárez, M. R., & Moreno, S. (2023). Is It Time for Treatment as Prevention of Chronic Hepatitis B?. Pathogens, 12(9), 1137. https://doi.org/10.3390/pathogens12091137
Vancouver
Perez-Molina JA, Cancio-Suárez MR, Moreno S. Is It Time for Treatment as Prevention of Chronic Hepatitis B?. Pathogens. 2023;12(9):1137. doi:10.3390/pathogens12091137
BibTeX
@article{PerezMolina2023,
author = {Perez-Molina, Jose A and Cancio-Suárez, Marta Rosas and Moreno, Santiago},
title = {Is It Time for Treatment as Prevention of Chronic Hepatitis B?},
journal = {Pathogens},
year = {2023},
volume = {12},
number = {9},
pages = {1137},
doi = {10.3390/pathogens12091137}
}
EUVIMED